Taken together, these observations suggest that activation of mTOR through loss of the TSC1/TSC2 repressor complex, or potentially by other means, is likely a common and critically pathogenic event in PEComas. The gene discussed is TSC2; the disease is neoplasm with perivascular epithelioid cell differentiation.